Replies to post #17201 on Biotech Values

[DewDiligence]

Perhaps you heard Dr. Saltz’s ASCO talk in #msg-8140742, which covered the very issues you’ve addressed.

Are you by any chance an oncologist? Have you been following the smoke-signal reading vis-à-vis Panitumumab?